Healthcare Resource Utilization (HCRU) in Patients (pts) with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) Treated in the Connect® MDS/AML Disease Registry

被引：0
|
作者：
Mukherjee, Sudipto [1 ]
Abedi, Mehrdad [2 ]
Erba, Harry P. [3 ]
Pollyea, Daniel A. [4 ]
Roboz, Gail J. [5 ]
Thompson, Michael A. [6 ]
Louis, Chrystal U. [7 ]
Flick, E. Dawn [8 ]
Nifenecker, Melissa [7 ]
Kiselev, Pavel [7 ]
Swern, Arlene S. [7 ]
Cogle, Christopher R. [9 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Colorado, Denver, CO 80202 USA
[5] Weill Cornell Med Coll, New York, NY USA
[6] Advocate Aurora Hlth, Aurora Res Inst, Milwaukee, WI USA
[7] Celgene Corp, Summit, NJ USA
[8] Celgene Corp, San Francisco, CA USA
[9] Univ Florida, Gainesville, FL USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-112935
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4736
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Hospitalization rates in elderly, newly diagnosed acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) patients treated with azacitidine.
    Ueda, Masumi
    Gupta, Divya
    Caimi, Paolo Fabrizio
    Creger, Richard
    Little, Jane
    William, Basem M.
    Lazarus, Hillard M.
    De Lima, Marcos J. G.
    Cooper, Brenda W.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Prognostic factors associated with progression of myelodysplastic syndromes (MDS) to acute myeloid leukemia (AML) in patients (pts) treated with decitabine.
    Fullmer, A.
    Borthakur, G.
    Kadia, T. M.
    Garcia-Manero, G.
    Jabbour, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] A phase II study of voreloxin as single agent therapy for elderly patients (pts) with newly diagnosed acute myeloid leukemia (AML)
    Maris, M. B.
    Ravandi, F.
    Stuart, R.
    Stone, R.
    Cripe, L.
    Cooper, M.
    Strickland, S.
    Turturro, F.
    Stock, W.
    Berman, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] PHASE I/II STUDY OF VOSAROXIN AND DECITABINE IN NEWLY DIAGNOSED OLDER PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)
    Daver, N.
    Kantarjian, H.
    Garcia-Manero, G.
    Jabbour, E.
    Borthakur, G.
    Pierce, S.
    Vaughan, K.
    Vaughan, K.
    Ning, J.
    Gonzalez, G.
    Pemmarjau, N.
    Kadia, T.
    Konopleva, M.
    Andreeff, M.
    DiNardo, C.
    Cortes, J.
    Ward, R.
    Craig, A.
    Ravandi, F.
    HAEMATOLOGICA, 2016, 101 : 187 - 188
  • [35] Clofarabine plus cytarabine (ARA-C) combination is active in newly diagnosed patients (pts) ≥ age 50 with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Faderl, S
    Gandhi, V
    Verstovsek, S
    Cortes, J
    Ravandi-Kashani, F
    Beran, M
    Garcia-Manero, G
    Koller, C
    O'Brien, S
    Ferrajoli, A
    Estrov, Z
    Kwari, M
    Plunkett, W
    Kantarjian, HM
    BLOOD, 2004, 104 (11) : 250A - 250A
  • [36] Albumin as a prognostic factor for overall survival in newly diagnosed patients with acute myeloid leukemia (AML).
    Khan, Awais M.
    Lancet, Jeffrey E.
    Kharfan-Dabaja, Mohamed A.
    Al Ali, Najla
    List, Alan F.
    Komrokji, Rami S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Myeloperoxidase (MPO) regulates the Clot Activation in newly diagnosed acute myeloid Leukemia (AML) Patients
    Rolling, C. C.
    Quick, H.
    Beitzen-Heineke, A.
    Janjetovic, S.
    Maeder, J.
    Lehr, C.
    Bokemeyer, C.
    Haddad, M.
    Renne, T.
    Fiedler, W.
    Beckmann, L.
    Klingler, F.
    Langer, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 32 - 32
  • [38] Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study
    Grinblatt, David L.
    Roboz, Gail J.
    Pollyea, Daniel A.
    Sekeres, Mikkael A.
    Scott, Bart L.
    Seiter, Karen
    Zeidan, Amer M.
    Patel, Jay L.
    Garcia-Manero, Guillermo
    Komrokji, Rami S.
    Savona, Michael R.
    Degutis, Irene S.
    Kiselev, Pavel
    Yu, Edward
    Heydendael, Willem
    Qiu, Ying
    Vergara, Sara
    McBride, Ali
    Erba, Harry P.
    BLOOD, 2023, 142
  • [39] Outcome of Patients (pts) Treated for Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (s AML) After Azacitidine (AZA) Failure
    Prebet, Thomas
    Gore, Steven D.
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Beach, C. L.
    Fenaux, Pierre
    Vey, Norbert
    BLOOD, 2010, 116 (21) : 199 - 199
  • [40] CONCOMITANT MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE (MGUS) IN NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA (MDS/AML)
    Chen, Mingyi
    La, Hanh
    Abedi, Mehrdad
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2014, 36 : 47 - 48
12345